HK1223928A1 - 新型結晶性芳烷基胺化合物及其製造方法 - Google Patents
新型結晶性芳烷基胺化合物及其製造方法Info
- Publication number
- HK1223928A1 HK1223928A1 HK16112135.3A HK16112135A HK1223928A1 HK 1223928 A1 HK1223928 A1 HK 1223928A1 HK 16112135 A HK16112135 A HK 16112135A HK 1223928 A1 HK1223928 A1 HK 1223928A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- producing same
- novel crystalline
- arylalkylamine compound
- crystalline arylalkylamine
- compound
- Prior art date
Links
- -1 arylalkylamine compound Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/50—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013073954 | 2013-09-05 | ||
PCT/JP2014/073426 WO2015034031A1 (ja) | 2013-09-05 | 2014-09-05 | 新規な結晶性アリールアルキルアミン化合物およびその製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1223928A1 true HK1223928A1 (zh) | 2017-08-11 |
Family
ID=52628492
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16112135.3A HK1223928A1 (zh) | 2013-09-05 | 2016-10-20 | 新型結晶性芳烷基胺化合物及其製造方法 |
HK18115431.5A HK1256344A1 (zh) | 2013-09-05 | 2018-12-03 | 製備氨基吡咯烷衍生物的方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18115431.5A HK1256344A1 (zh) | 2013-09-05 | 2018-12-03 | 製備氨基吡咯烷衍生物的方法 |
Country Status (8)
Country | Link |
---|---|
US (2) | US9643920B2 (zh) |
EP (2) | EP3360858B1 (zh) |
KR (6) | KR102460388B1 (zh) |
CN (2) | CN108484469A (zh) |
ES (2) | ES2699884T3 (zh) |
HK (2) | HK1223928A1 (zh) |
TW (1) | TWI637943B (zh) |
WO (1) | WO2015034031A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017061621A1 (ja) * | 2015-10-07 | 2017-04-13 | 協和発酵キリン株式会社 | アリールアルキルアミン化合物含有医薬組成物 |
JP6168673B2 (ja) * | 2015-10-07 | 2017-07-26 | 協和発酵キリン株式会社 | アリールアルキルアミン化合物含有医薬組成物 |
CN110167916B (zh) * | 2017-01-13 | 2022-11-11 | 日产化学株式会社 | 芳香族二胺化合物前体的制造方法 |
JP2020105072A (ja) * | 2017-03-24 | 2020-07-09 | 協和キリン株式会社 | ポリエチレングリコール誘導体 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4432987A (en) * | 1982-04-23 | 1984-02-21 | Pfizer Inc. | Crystalline benzenesulfonate salts of sultamicillin |
ZA941586B (en) * | 1993-03-12 | 1995-09-07 | Upjohn Co | Crystalline ceftiofur free acid |
JPH0812670A (ja) * | 1994-04-26 | 1996-01-16 | Kissei Pharmaceut Co Ltd | 新規なピロリジン誘導体 |
USRE40794E1 (en) * | 2001-09-26 | 2009-06-23 | Merck & Co., Inc. | Crystalline forms of carbapenem antibiotics and methods of preparation |
PL1757582T3 (pl) | 2004-05-28 | 2016-04-29 | Mitsubishi Tanabe Pharma Corp | Aryloalkiloaminy i sposób ich wytwarzania |
JPWO2009107579A1 (ja) * | 2008-02-25 | 2011-06-30 | 味の素株式会社 | コク味付与剤 |
JP5748666B2 (ja) | 2008-12-09 | 2015-07-15 | インテルキム、ソシエダッド アノニマ | (6s)−(−)−5,6,7,8−テトラヒドロ−6−[プロピル−(2−チエニル)エチル]アミノ−1−ナフトール(ロチゴチン)の製造のための方法 |
MX2011012537A (es) | 2009-05-29 | 2011-12-14 | Sumitomo Chemical Co | Agente para el tratamiento o prevencion de enfermedades asociadas con actividad de factores neurotroficos. |
-
2014
- 2014-09-05 KR KR1020217030803A patent/KR102460388B1/ko active IP Right Grant
- 2014-09-05 EP EP18163078.1A patent/EP3360858B1/en active Active
- 2014-09-05 CN CN201810320607.6A patent/CN108484469A/zh active Pending
- 2014-09-05 CN CN201480048754.2A patent/CN105517992B/zh active Active
- 2014-09-05 TW TW103130724A patent/TWI637943B/zh active
- 2014-09-05 ES ES14842038T patent/ES2699884T3/es active Active
- 2014-09-05 EP EP14842038.3A patent/EP3042893B1/en active Active
- 2014-09-05 ES ES18163078T patent/ES2795227T3/es active Active
- 2014-09-05 KR KR1020227036990A patent/KR102601941B1/ko active IP Right Grant
- 2014-09-05 KR KR1020177024057A patent/KR102177643B1/ko active IP Right Grant
- 2014-09-05 WO PCT/JP2014/073426 patent/WO2015034031A1/ja active Application Filing
- 2014-09-05 KR KR1020167008544A patent/KR20160051833A/ko not_active Application Discontinuation
- 2014-09-05 KR KR1020237038676A patent/KR20230159631A/ko not_active Application Discontinuation
- 2014-09-05 US US14/916,859 patent/US9643920B2/en active Active
- 2014-09-05 KR KR1020207022018A patent/KR20200093705A/ko not_active Application Discontinuation
-
2016
- 2016-10-20 HK HK16112135.3A patent/HK1223928A1/zh unknown
-
2017
- 2017-03-30 US US15/474,846 patent/US10144708B2/en active Active
-
2018
- 2018-12-03 HK HK18115431.5A patent/HK1256344A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20210119581A (ko) | 2021-10-05 |
EP3360858A1 (en) | 2018-08-15 |
US9643920B2 (en) | 2017-05-09 |
CN105517992A (zh) | 2016-04-20 |
EP3042893A1 (en) | 2016-07-13 |
CN108484469A (zh) | 2018-09-04 |
CN105517992B (zh) | 2018-06-22 |
KR102601941B1 (ko) | 2023-11-15 |
EP3042893A4 (en) | 2017-02-15 |
KR102460388B1 (ko) | 2022-10-27 |
WO2015034031A1 (ja) | 2015-03-12 |
TWI637943B (zh) | 2018-10-11 |
EP3360858B1 (en) | 2020-04-29 |
US20160200679A1 (en) | 2016-07-14 |
KR20230159631A (ko) | 2023-11-21 |
US10144708B2 (en) | 2018-12-04 |
ES2795227T3 (es) | 2020-11-23 |
TW201546045A (zh) | 2015-12-16 |
KR102177643B1 (ko) | 2020-11-11 |
US20170267633A1 (en) | 2017-09-21 |
KR20160051833A (ko) | 2016-05-11 |
ES2699884T3 (es) | 2019-02-13 |
HK1256344A1 (zh) | 2019-09-20 |
KR20200093705A (ko) | 2020-08-05 |
KR20220150994A (ko) | 2022-11-11 |
EP3042893B1 (en) | 2018-10-31 |
KR20170102375A (ko) | 2017-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2955169A4 (en) | Novel aryl compound and method for producing the same | |
PL3006568T3 (pl) | Sposób wytwarzania tagatozy | |
EP3020688A4 (en) | ZEOLITE PROCESS | |
EP3037087A4 (en) | Method for producing microparticles | |
PT2948590T (pt) | Método para produção de lenhina de elevada pureza | |
PT3466431T (pt) | Formas cristalinas e métodos para preparação de inibidores de sglt2 | |
EP3087961A4 (en) | METHOD FOR PRODUCING A VACUUMABLE ARTICLE | |
IL244740B (en) | A production method for a diazabicyclooctane derivative and an intermediate compound therefor | |
EP2990409A4 (en) | PROCESS FOR PRODUCING A NEW ORGANOMETALLIC COMPLEX AND AN AMINO COMPOUND | |
EP2977353A4 (en) | PROCESS FOR PRODUCING POTASSIUM TITANATE | |
EP3042960A4 (en) | Method for producing ambrein | |
EP2980066A4 (en) | PROCESS FOR PRODUCING ISOCYANATE | |
SG11201508263WA (en) | Method for producing cyclohexanone compound | |
EP2998395A4 (en) | METHOD FOR OBTAINING COMPOSITION CONTAINING LACTASE | |
EP3061352A4 (en) | Method for producing kakiage | |
EP3051009A4 (en) | SIC-EINKRISTALL AND METHOD FOR THE PRODUCTION THEREOF | |
EP2808376A4 (en) | PROCESS FOR PRODUCING A COMPOSITION | |
HK1223928A1 (zh) | 新型結晶性芳烷基胺化合物及其製造方法 | |
EP2980019A4 (en) | PROCESS FOR THE PREPARATION OF DDR ZEOLITE CRYSTALS AND METHOD FOR THE PRODUCTION OF A DDR ZEOLITHFOLIR | |
EP2985369A4 (en) | METHOD FOR PRODUCING A SILICON INCREDIENT | |
EP3026146A4 (en) | METHOD FOR MANUFACTURING SiC SUBSTRATES | |
EP3077414A4 (en) | Method for preparing crystalline insulin | |
PL3069610T3 (pl) | Ko-kryształ i sposób jego wytwarzania | |
HUE037846T2 (hu) | Eljárás izocianátok elõállítására | |
EP2842930A4 (en) | PROCESS FOR PRODUCING HYDROXYPHENYLCYCLOHEXANOL COMPOUND |